Skip to main content
Fig. 2 | Harm Reduction Journal

Fig. 2

From: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Fig. 2

Treatment retention by proportion of BZD-positive urine samples. A Cox proportional hazard analysis was used to characterize the time to treatment discontinuation across the four patient groups. Patients with 25–50% of urines BZD-positive were 26.6% more likely to drop out of treatment than patients in the 0–25% reference group [aHR = 1.26 (95% CI 1.02–1.57)]. Patients with 50–75% of urines BZD-positive were 37.4% more likely to drop out of treatment than patients in the 0–25% reference group [aHR = 1.37(95% CI 1.03–1.832)]. Patients with 75–100% of urines BZD positive were 174.4% more likely to drop out of treatment than patients in the 0–25% reference group [aHR = 2.74(95% CI 2.19–3.43)]

Back to article page

Harm Reduction Journal

ISSN: 1477-7517